A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Clinical trial NCT00871559 · COMPLETED
Trial details
- NCT number
- NCT00871559
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.